Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ping An Biomedical (PASW) Cash & Current Investments (2024 - 2025)

Ping An Biomedical filings provide 2 years of Cash & Current Investments readings, the most recent being $5.1 million for Q3 2025.

  • On a quarterly basis, Cash & Current Investments rose 27966.69% to $5.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $5.1 million, a 27966.69% increase, with the full-year FY2025 number at $5.1 million, up 27764.94% from a year prior.
  • Cash & Current Investments hit $5.1 million in Q3 2025 for Ping An Biomedical, up from $15084.4 in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $5.1 million in Q3 2025 to a low of $15084.4 in Q1 2025.